Effects of orally administered moxaverine on ocular blood flow in healthy subjects

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 2, 2013, Pages 515-520

  Schmidl, Doreen ^a   Pemp, Berthold ^a   Lasta, Michael ^a   Boltz, Agnes ^a,b   Kaya, Semira ^a   Palkovits, Stefan ^a   Prager, Franz ^a   Schmetterer, Leopold ^a,b   Garhofer, Gerhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

Author keywords

Color doppler imaging; Laser doppler flowmetry; Moxaverine; Ocular blood flow

Indexed keywords

KOLLATERAL FORTE; MOXAVERINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW VELOCITY; CHOROID; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYE BLOOD FLOW; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; OPTIC NERVE; OUTCOME VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CHOROID; CILIARY ARTERIES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; OPHTHALMIC ARTERY; OPTIC DISK; PAPAVERINE; PARASYMPATHOLYTICS; REGIONAL BLOOD FLOW; RETINAL ARTERY; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 84877124398     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2207-1     Document Type: Article

References (38)

1. Grover DS, Budenz DL (2011) Ocular perfusion pressure and glaucoma. Int Ophthalmol Clin 51:19-25
2. Pemp B, Schmetterer L (2008) Ocular blood flow in diabetes and age-related macular degeneration. Can J Ophthalmol 43:295-301
3. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359-393
4. DelMonte DW, Bhatti MT (2009) Ischemic optic neuropathy. Int Ophthalmol Clin 49:35-62
5. Schmidl D, Garhofer G, Schmetterer L (2011) The complex interaction between ocular perfusion pressure and ocular blood flow - Relevance for glaucoma. Exp Eye Res 93:141-155
6. Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603-607
7. Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, Martin B (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80:468-477
8. Araie M, Mayama C (2011) Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 30:54-71
9. Gaspar AZ, Gasser P, Flammer J (1995) The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 209:11-13
10. Aydin B, Onol M, Hondur A, Kaya MG, Ozdemir H, Cengel A, Hasanreisoglu B (2010) The effect of oral magnesium therapy on visual field and ocular blood flow in normotensive glaucoma. Eur J Ophthalmol 20:131-135
11. Matulla B, Streit G, Pieh S, Findl O, Entlicher J, Graselli U, Eichler HG, Wolzt M, Schmetterer L (1997) Effects of losartan on cerebral and ocular circulation in healthy subjects. Br J Clin Pharmacol 44:369-375
12. Hirooka K, Shiraga F (2007) Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma. Clin Ophthalmol 1:217-223
13. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R (1999) Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 15:233-240
14. Rainer G, Kiss B, Dallinger S, Findl O, Georgopoulos M, Vass C, Menapace R, Polak K, Eichler HG, Wolzt M, Schmetterer L (2001) A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma. Br J Clin Pharmacol 52:210-212
15. Resch H, Weigert G, Karl K, Pemp B, Garhofer G, Schmetterer L (2009) Effect of systemic moxaverine on ocular blood flow in humans. Acta Ophthalmol 87:731-735
16. Pemp B, Garhofer G, Lasta M, Schmidl D, Wolzt M, Schmetterer L (2012) The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects. Acta Ophthalmologica 90:139-145
17. Polska E, Polak K, Luksch A, Fuchsjager-Mayrl G, Petternel V, Findl O, Schmetterer L (2004) Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol 88:533-537
18. Luksch A, Lasta M, Polak K, Fuchsjager-Mayrl G, Polska E, Garhofer G, Schmetterer L (2009) Twelve-hour reproducibility of retinal and optic nerve blood flow parameters in healthy individuals. Acta Ophthalmol 87:875-880
19. Ursapharm (1987) Pharmakokinetik von Moxaverin per os unter Mehrfachdosisbedingungen. Iphar Study 87/253
20. Ursapharm (2010) Kollateral forte 150 mg dragees: prescribing information. Edition 3/2010
21. Lieb WE, Cohen SM, Merton DA, Shields JA, Mitchell DG, Goldberg BB (1991) Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy. Arch Ophthalmol 109:527-531
22. Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G, Grunwald J, Gugleta K, Harris A, Hudson C, Januleviciene I, Kagemann L, Kergoat H, Lovasik JV, Lanzl I, Martinez A, Nguyen QD, Plange N, Reitsamer HA, Sehi M, Siesky B, Zeitz O, Orgul S, Schmetterer L (2011) Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol 89:e609-630
23. Riva CE, Harino S, Petrig BL, Shonat RD (1992) Laser Doppler flowmetry in the optic nerve. Exp Eye Res 55:499-506
24. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL (1994) Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci 35:4273-4281
25. Riva CE, Geiser M, Petrig BL (2010) Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmol 88:622-629
26. Schmetterer L, Kemmler D, Breiteneder H, Alschinger C, Koppensteiner R, Lexer F, Fercher AF, Eichler HG, Wolzt M (1996) A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol 121:169-176
27. Sonkin PL, Kelly LW, Sinclair SH, Hatchell DL (1993) Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch Ophthalmol 111:1647-1652
28. Sonkin PL, Sinclair SH, Hatchell DL (1993) The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity. Am J Ophthalmol 115:775-780
29. Kruger A, Matulla B, Wolzt M, Pieh S, Strenn K, Findl O, Eichler HG, Schmetterer L (1998) Short-term oral pentoxifylline use increases choroidal blood flow in patients with age-related macular degeneration. Arch Ophthalmol 116:27-30
30. Paris G, Sponsel WE, Sandoval SS, Elliott WR, Trigo Y, Sanford DK, Harrison JM (2001) Sildenafil increases ocular perfusion. Int Ophthalmol 23:355-358
31. Polak K, Wimpissinger B, Berisha F, Georgopoulos M, Schmetterer L (2003) Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Invest Ophthalmol Vis Sci 44:4872-4876
32. Dundar SO, Dundar M, Kocak I, Dayanir Y, Ozkan SB (2001) Effect of sildenafil on ocular haemodynamics. Eye (Lond) 15:507-510
33. Mannhold R (1988) Inhibition of calmodulin dependent c-AMP- phosphodiesterase by moxaverine and papaverine. Arzneimittelforschung 38:1806-1808
34. Berg G, Andersson RG, Ryden G (1987) Effects of different phosphodiesterase-inhibiting drugs on human pregnant myometrium: an in vitro study. Arch Int Pharmacodyn Ther 290:288-292
35. Schmid-Schonbein H, Schroder S, Grebe R, Artmann G, Eschweiler H, Teitel P (1988) Influence of moxaverine hydrochloride on membrane curvature and microsieve filterability of red cells after exposure to hyperosmolarity and lactacidosis. Arzneimittelforschung 38:710-716
36. Feine-Haake G, Haase W, Weschenfelder R (1977) Treatment of cerebrovascular disorders using Kollateral-P degrees. Open long-term study in a home for the aged. Ther Ggw 116:1348-1358
37. Feine-Haake G, Neiss A, Weinert W (1975) The treatment of cerebrovascular insufficiency. Their evaluation in a double-blind study. MMW Munch Med Wochenschr 117:1131-1132
38. Nordeck H, Eichler K, Mulch R, Volker D (1971) Collateral dilatation therapy in coronary and peripheral arterial occlusive diseases. Experimental and clinical experiences with 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride (BEN). Munch Med Wochenschr 113:1006-1011